Targeting NAD+: is it a common strategy to delay heart aging?

Heart aging is the main susceptible factor to coronary heart disease and significantly increases the risk of heart failure, especially when the aging heart is suffering from ischemia-reperfusion injury. Numerous studies with NAD+ supplementations have suggested its use in anti-aging treatment. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Yang, Liang, Bing, Liu, Xin-Lin, Liu, Wen-Jing, Huang, Bing-Huan, Yang, Shan-Bo, Gao, Yuan-Zhen, Meng, Jing-Sen, Li, Meng-Jiao, Ye, Ting, Wang, Chuan-Zhi, Hu, Xiao-Kun, Xing, Dong-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042931/
https://www.ncbi.nlm.nih.gov/pubmed/35474295
http://dx.doi.org/10.1038/s41420-022-01031-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042931/
https://www.ncbi.nlm.nih.gov/pubmed/35474295
http://dx.doi.org/10.1038/s41420-022-01031-3

Ejemplares similares